Inventor · disambiguated record
Frank-Gerhard Boss
Also filed as: BOESS FRANK · BOESS FRANK-GERHARD · BOSS FRANK-GERHARD · Böss Frank-Gerhard
11 granted patents·2 pending applications·121 citations·filing 1999–2013
90Inventor score
Files withBAYER AG4BAYER HEALTHCARE AG3BOESS FRANK-GERHARD2BAYER SCHERING PHARMA AG1Böss Frank-Gerhard1
Top patents by PatentIndex Score
13 records- 0186US6573263B2Substituted imidazotriazinonesBAYER AG·Filed 2001·Granted Jun 3, 2003·29 cites·11 claims
- 0284US8153799B2Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsFLESSNER TIMO·Filed 2010·Granted Apr 10, 2012·6 cites·12 claims
- 0383US6589949B13-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseasesBAYER AG·Filed 2000·Granted Jul 8, 2003·23 cites·10 claims
- 0482US7256288B2Heteroaryl carboxylic acid amidesBAYER HEALTHCARE AG·Filed 2002·Granted Aug 14, 2007·13 cites·5 claims
- 0581US7022709B2Selective PDE 2 inhibitors as pharmaceuticals for improving perceptionBOESS FRANK-GERHARD·Filed 2001·Granted Apr 4, 2006·21 cites·2 claims
- 0677US6998402B2Substituted imidazotriazinonesBAYER AG·Filed 2002·Granted Feb 14, 2006·11 cites·11 claims
- 0776US7247728B2Bicyclic N-arylamidesBAYER HEALTHCARE AG·Filed 2002·Granted Jul 24, 2007·9 cites·7 claims
- 0875US7138410B2Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptorBAYER HEALTHCARE AG·Filed 2003·Granted Nov 21, 2006·9 cites·13 claims
- 0960US2011263591A12-heteroaryl carboxamidesBAYER SCHERING PHARMA AG·Filed 2011·Application pending·0 cites
- 1057US2012258964A12-heteroaryl carboxamidesLUITHLE JOACHIM·Filed 2012·Application pending·0 cites
- 1153US9067945B2Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processesBöss Frank-Gerhard·Filed 2013·Granted Jun 30, 2015·0 cites·14 claims
- 1250US8455502B2Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processesBOESS FRANK-GERHARD·Filed 2010·Granted Jun 4, 2013·0 cites·9 claims
- 1329US6344471B12-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseasesBAYER AG·Filed 1999·Granted Feb 5, 2002·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →